Today, Dr. Marcia Nißen, Alexandre de Montleau, Felix Moser, Marinja Principe and Sophie Krenböck, all members of the PRECIOUS – our flagship project aiming to develop a design and trial service for precision digital therapeutics – team, attended the Swiss Clinical Trial Ogranisation (SCTO) Symposium 2025 in Basel. The team aimed to connect with the clinical research community and explore how digital tools like PRECIOUS can better support clinical trials embedded in everyday care. The event sparked valuable discussions about the future of clinical trials, the importance of real-world data, digital health, and pragmatic trial designs. It also underscored the need for regulatory frameworks and ethical oversight mechanisms that evolve alongside technological innovation.

These conversations reinforced PRECIOUS as a promising platform at this intersection.